SAN DIEGO--(BUSINESS WIRE)--Ardea Biosciences, Inc. (Nasdaq:RDEA), a biotechnology company focused on the discovery and development of small-molecule therapeutics for the treatment of gout, human immunodeficiency virus (HIV), cancer and inflammatory diseases, today announced event participants and webcast information for its Investor and Analyst Event on Monday, April 20, 2009 from 5:00 p.m. to 7:00 p.m. Eastern Daylight Time in New York City.
